Plasma protein-binding parameters of prednisolone in immune disease patients receiving long-term prednisone therapy.
Prednisone and prednisolone bind in plasma to albumin and transcortin. In am attempt to determine whether prednisone side effects and/or type of disease correlated with prednisolone plasma protein binding, multiple plasma samples from 17 patients (three asthma, eight SLE, three RA, two PSS, one PAN) receiving long-term prednisone therapy were monitored during an interval between two prednisone doses. Prednisolone plasma protein binding was nonlinear and exhibited large intrapatient and interpatient variability. For the group, mean association constants of the prednisolone-albumin complex and the prednisolone-transcortin complex were 2.3 X 10(3) M-1 and 2.9 X 10(7) M-1, with coefficients of variation of 82% and 127%, respectively. SLE patients tended to have lower mean prednisolone association constants for albumin and transcortin than did other patients. The presence of corticosteroid side effects did not correlate with prednisolone plasma protein-binding parameters. The wide range of prednisolone free fraction noted in plasma from patients who achieved comparable total prednisolone plasma concentrations implies that administration of a uniform prednisone dose will not lead to a predictable clinical response.
D000293:Adolescent; D000328:Adult; D001798:Blood Proteins / Q000378:metabolism*; D005260:Female; D006801:Humans; D007154:Immune System Diseases / Q000188:drug therapy / Q000378:metabolism*; D007206:Individuality; D008297:Male; D008875:Middle Aged; D011239:Prednisolone / Q000378:metabolism*; D011241:Prednisone / Q000627:therapeutic use*; D011485:Protein Binding; D013997:Time Factors
D001798:Blood Proteins; D011239:Prednisolone; D011241:Prednisone